Lactam inhibitors of Hepatitis C virus NS3 protease
US7122627B2 · kind B2 · utility
29Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2001 |
| Grant date | Oct 17, 2006 |
| Priority date | — |
| Expiry date | Apr 29, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to lactams of Formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.